Literature DB >> 12784070

The first description of a device for repeated external ventricular drainage in the treatment of congenital hydrocephalus, invented in 1744 by Claude-Nicolas Le Cat.

E J O Kompanje1, E J Delwel.   

Abstract

An 18th century report of a device for repeated extracranial drainage of cerebrospinal fluid in the treatment of congenital hydrocephalus is reviewed. On 15th October 1744, the French surgeon Claude-Nicolas Le Cat (1700-1768) introduced a specially invented canula into the lateral ventricle of a newborn boy with hydrocephalus. The canula was used as a tap and was left in place for 5 days, until the death of the child. This procedure should be seen as the first documented description of a device for repeated ventricular taps in the treatment of hydrocephalus. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12784070     DOI: 10.1159/000070872

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  9 in total

Review 1.  The ventricular system of the brain: a comprehensive review of its history, anatomy, histology, embryology, and surgical considerations.

Authors:  M M Mortazavi; N Adeeb; C J Griessenauer; H Sheikh; S Shahidi; R I Tubbs; R S Tubbs
Journal:  Childs Nerv Syst       Date:  2013-11-16       Impact factor: 1.475

2.  A historical glimpse into treating childhood hydrocephalus.

Authors:  Amin Demerdash; Rajani Singh; Marios Loukas; R Shane Tubbs
Journal:  Childs Nerv Syst       Date:  2015-02-24       Impact factor: 1.475

3.  External ventricular drainage: indications and outcome among Sudanese Children.

Authors:  Mohammed Awad Elzain; Moayad Moawia Ahmed; Abubakr Darrag Salim
Journal:  Sudan J Paediatr       Date:  2022

4.  Comparative Effectiveness of Diversion of Cerebrospinal Fluid for Children With Severe Traumatic Brain Injury.

Authors:  Michael J Bell; Bedda L Rosario; Patrick M Kochanek; P David Adelson; Kevin P Morris; Alicia K Au; Michelle Schober; Warwick Butt; Richard J Edwards; Jerry Zimmerman; Jose Pineda; Truc M Le; Nathan Dean; Michael J Whalen; Anthony Figaji; James Luther; Sue R Beers; Deepak K Gupta; Jessica Carpenter; Sandra Buttram; Stephen R Wisniewski
Journal:  JAMA Netw Open       Date:  2022-07-01

5.  The Role of Antisiphon Devices in the Prevention of Central Ventricular Catheter Obliteration for Hydrocephalus: A 15-Years Institution's Experience Retrospective Analysis.

Authors:  Dimitrios Panagopoulos; Georgios Strantzalis; Maro Gavra; Efstathios Boviatsis; Stefanos Korfias
Journal:  Children (Basel)       Date:  2022-04-01

6.  Cerebrospinal fluid flow on time-spatial labeling inversion pulse images before and after treatment of congenital hydrocephalus in a dog.

Authors:  Daisuke Ito; Chieko Ishikawa; Nick D Jeffery; Masato Kitagawa
Journal:  J Vet Intern Med       Date:  2021-01-09       Impact factor: 3.175

7.  Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland.

Authors:  Aimun A B Jamjoom; Alexis J Joannides; Michael Tin-Chung Poon; Aswin Chari; Malik Zaben; Mutwakil A H Abdulla; Joy Roach; Laurence J Glancz; Anna Solth; John Duddy; Paul M Brennan; Roger Bayston; Diederik O Bulters; Conor L Mallucci; Michael D Jenkinson; William P Gray; Jothy Kandasamy; Peter J Hutchinson; Angelos G Kolias; Aminul I Ahmed
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-10-25       Impact factor: 13.654

8.  Intracranial Pressure during External Ventricular Drainage Weaning Is an Outcome Predictor of Traumatic Brain Injury.

Authors:  Jia-Cheng Gu; Hong Wu; Xing-Zhao Chen; Jun-Feng Feng; Guo-Yi Gao; Ji-Yao Jiang; Qing Mao
Journal:  Biomed Res Int       Date:  2020-07-09       Impact factor: 3.411

Review 9.  The Evolution of the Role of External Ventricular Drainage in Traumatic Brain Injury.

Authors:  Charlene Y C Chau; Claudia L Craven; Andres M Rubiano; Hadie Adams; Selma Tülü; Marek Czosnyka; Franco Servadei; Ari Ercole; Peter J Hutchinson; Angelos G Kolias
Journal:  J Clin Med       Date:  2019-09-10       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.